生物活性 靶点 体外研究 体内研究 补骨脂定 试剂级价格
ChemicalBook  CAS数据库列表  补骨脂定

补骨脂定

补骨脂定,18642-23-4,结构式
补骨脂定
  • CAS号:18642-23-4
  • 英文名:psoralidin
  • 中文名:补骨脂定
  • CBNumber:CB41384552
  • 分子式:C20H16O5
  • 分子量:336.34
  • MOL File:18642-23-4.mol
补骨脂定化学性质
  • 熔点 :290-292°
  • 沸点 :458.8±34.0 °C(Predicted)
  • 密度 :1.383±0.06 g/cm3(Predicted)
  • 储存条件 :Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
  • 溶解度 :DMSO: soluble5mg/mL, clear (warmed)
  • 形态 :powder
  • 酸度系数(pKa) :8.70±0.20(Predicted)
  • 颜色 :white to beige
  • InChIKey :YABIJLLNNFURIJ-UHFFFAOYSA-N
安全信息
  • WGK Germany :3
  • 海关编码 :2932.20.4500

补骨脂定性质、用途与生产工艺

  • 生物活性 Psoralidin 是从 Psoralea corylifolia 的种子中分离出来的,是 COX-2 和 5-LOX 的双重抑制剂。具有抗癌,抗菌和抗炎作用。Psoralidin 显著下调 NOTCH1 信号传导。Psoralidin 还极大地诱导 ROS 产生。
  • 靶点

    COX-2

    5-LOX

  • 体外研究

    Three breast cancer cell (BCC)populations (ALDH - cells, ALDH + cells, and commercial BSCSs) are sensitive to Psoralidin treatment (10, 15, 20, and 25 μM; 24 hours) with IC 50 s ranging from 18 to 21 μM; however, the MCF-12A cells were resistant to Psoralidin.
    Psoralidin (30 μM; 24 hours) results in a significant induction of apoptosis for ALDH - cells, ALDH + cells, and commercial BCSCs.
    Psoralidin treatment also downregulates NOTCH1 expression in both ALDH - and ALDH + cells.

    Cell Viability Assay

    Cell Line: ALDH - cells, ALDH + cells, commercial breast cancer stem cells (BSCSs), and normal breast epithelial cells (MCF-12A)
    Concentration: 10, 15, 50, and 25 μM
    Incubation Time: 24 hours
    Result: IC 50 s of 18 to 21 μM for ALDH - cells, ALDH + cells, commercial BCSCs.

    Apoptosis Analysis

    Cell Line: ALDH - cells, ALDH + cells, and commercial BCSCs
    Concentration: 20 and 30 μM
    Incubation Time: 24 hours
    Result: No significant induction of apoptosis was observed for any of the three cell types following treatment at 20 μM. However, 53.60%, 44.1%, and 45.9% of cells were apoptotic at 30 μMin ALDH - cells, ALDH + cells, and commercial BCSCs, respectively.
  • 体内研究

    Psoralidin (5 mg/kg) regulates expression of pro-inflammatory cytokines that play an important role in inflammatory diseasesin IR-irradiated lung of BALB/c mouse.

    Animal Model: BALB/c mice
    Dosage: 5 mg/kg
    Administration: Intraperitoneal application; 30 min before and 1 h after IR irradiation (20 Gy).
    Result: Anti-inflammatory effect in IR-irradiated mice.
  • 化学性质  淡黄色结晶粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于补骨脂Psoralea corylifolia Linn.种子。
  • 用途  补骨脂定具有抗真菌,细胞毒,扩张冠状动脉、止血的作用。
  • 用途  一种ptp1b抑制剂,具有多种抗癌作用机制。
补骨脂定上下游产品信息
上游原料
下游产品
补骨脂定 试剂级价格
  • 更新日期:2024/11/08
  • 产品编号:HY-N0232
  • 产品名称:补骨脂定 Psoralidin
  • CAS编号:18642-23-4
  • 包装:5mg
  • 价格:600元
  • 更新日期:2024/11/08
  • 产品编号:HY-N0232
  • 产品名称:补骨脂定 Psoralidin
  • CAS编号:
  • 包装:10 mM * 1 mLin DMSO
  • 价格:660元
补骨脂定生产厂家
  • 公司名称:AXXORA, LLC
  • 联系电话:--
  • 电子邮件:alexis-ch@alexis-corp.com
  • 国家:瑞士
  • 产品数:1104
  • 优势度:80
18642-23-4, 补骨脂定相关搜索: